Study guide
3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
Key Takeaways Explain This Topic AI
Crohn's disease is characterized by transmural inflammation, skip lesions, non-caseating granulomas, and perianal fistulae, whereas Ulcerative Colitis exhibits continuous mucosal involvement starting from the rectum.
Primary Sclerosing Cholangitis (PSC) is strongly associated with Ulcerative Colitis (~80% of PSC patients have underlying UC) and increases colorectal cancer risk requiring annual screening colonoscopy.
Celiac disease is an autoimmune enteropathy triggered by gluten (gliadin) associated with HLA-DQ2/DQ8; anti-tTG IgA is the screening test of choice, and duodenal biopsy showing villous atrophy is diagnostic.
Whipple disease is caused by Tropheryma whipplei, presenting with malabsorption, arthralgias, hyperpigmentation, and pathognomonic PAS-positive, acid-fast negative macrophages on small bowel biopsy.
Last updated: July 2026
Inflammatory Bowel Disease & Malabsorption Syndromes
Inflammatory Bowel Disease (IBD) and Malabsorption Syndromes constitute major gastroenterology topics in UPSC CMS. Exam items test the pathological and clinical distinctions between Crohn's Disease and Ulcerative Colitis, extraintestinal manifestations, Celiac disease serology/biopsy, Tropical sprue, and Whipple disease.
Crohn's Disease vs. Ulcerative Colitis
Inflammatory bowel disease encompasses two primary chronic relapsing idiopathic inflammatory disorders of the gastrointestinal tract.
Feature Crohn's Disease (CD) Ulcerative Colitis (UC)
Anatomical Distribution Any segment from mouth to anus; Terminal ileum involved in 70–80%; Rectal sparing common Restricted to colon; Rectum involved in 95% ; extends continuously proximally
Pattern of Involvement Skip lesions (discontinuous areas of inflammation separated by normal mucosa) Continuous inflammation extending from rectum without skip lesions
Depth of Inflammation Transmural (full thickness of bowel wall) Mucosal and submucosal only
Gross Endoscopic Appearance Cobblestone mucosa (deep linear ulcers separating edematous mucosa), aphthous ulcers, creeping fat Diffuse hyperemia, granular friable mucosa, superficial ulcerations, pseudopolyps
Histopathology Non-caseating granulomas (30–50% pathognomonic finding), transmural lymphoid aggregates Crypt abscesses (neutrophils in crypt lumen), crypt distortion/atrophy
Complications Strictures, intestinal obstruction, fistulae (enterocutaneous, enteroenteric, enterovesical), perianal abscesses Toxic megacolon (transverse colon diameter > 6 cm >6\text{ cm} > 6 cm ), severe hemorrhage, Colorectal Carcinoma
Serology ASCA (+) (Anti-Saccharomyces cerevisiae antibodies) p-ANCA (+) (Perinuclear antineutrophil cytoplasmic antibodies)
Smoking Effect Smoking worsens disease progression and relapse risk Smoking is protective (ex-smokers have higher risk of UC relapse)
Surgical Cure Non-curable; surgery reserved for complications (segmental resection) Curable by total proctocolectomy with ileal pouch-anal anastomosis (IPAA)
Extraintestinal Manifestations of IBD
Hepatobiliary: Primary Sclerosing Cholangitis (PSC) – strongly associated with Ulcerative Colitis ( 70 − 80 % 70-80\% 70 − 80% of PSC patients have UC). Manifests with concentric onion-skin fibrosis of bile ducts, p-ANCA positivity, and increased risk of cholangiocarcinoma.
Dermatologic:
Erythema Nodosum: Painful, tender red subcutaneous nodules on anterior shins; correlates with intestinal disease activity (more common in CD).
Pyoderma Gangrenosum: Violaceous, necrotic ulceration with undermined purulent edges; independent of intestinal disease activity (more common in UC).
Ocular: Episcleritis (correlates with bowel inflammation), Uveitis (painful, photophobia, cell & flare on slit-lamp; HLA-B27 associated).
Musculoskeletal: Peripheral enteropathic arthritis (Type I pauciarticular; Type II polyarticular), Ankylosing Spondylitis (HLA-B27 associated, independent of IBD course).
Pharmacotherapy of IBD
5-Aminosalicylates (5-ASA / Mesalamine, Sulfasalazine): First-line induction and maintenance for mild-to-moderate Ulcerative Colitis.
Corticosteroids (Prednisone, Budesonide): Highly effective for acute flare induction; strictly contraindicated for long-term maintenance due to systemic toxicity.
Immunomodulators (Azathioprine, 6-Mercaptopurine, Methotrexate): Used for steroid-sparing maintenance in moderate-to-severe IBD. Requires thiopurine methyltransferase (TPMT) testing prior to initiation.
Biologic Therapies:
Anti-TNF- α \alpha α agents: Infliximab , Adalimumab.
Anti-integrin ( α 4 β 7 \alpha_4\beta_7 α 4 β 7 ): Vedolizumab (gut-selective).
Anti-IL-12/IL-23: Ustekinumab .
Malabsorption Syndromes
Malabsorption is impaired mucosal absorption of nutrients from the small intestine.
1. Celiac Disease (Gluten-Sensitive Enteropathy)
Pathogenesis: Immune-mediated enteropathy triggered by ingestion of dietary gluten (specifically gliadin peptides found in wheat, rye, and barley) in genetically susceptible individuals expressing HLA-DQ2 ( 95 % 95\% 95% ) or HLA-DQ8 ( 5 % 5\% 5% ).
Clinical Manifestations: Chronic diarrhea, abdominal distension, failure to thrive, iron-deficiency anemia refractory to oral iron, dermatitis herpetiformis (intensely pruritic papulovesicular rash on extensor surfaces).
Diagnostic Protocol:
Serology (Initial Screening): IgA anti-Tissue Transglutaminase ( anti-tTG IgA ) antibody + Total serum IgA level (to exclude selective IgA deficiency). Quantitative IgA anti-endomysial antibodies (EMA IgA) provide near 100% specificity.
Duodenal Biopsy (Gold Standard): Multiple endoscopic mucosal biopsies of the second/third portion of the duodenum demonstrating Marsh Criteria :
Marsh 1: Increased Intraepithelial Lymphocytes (IELs > 25 >25 > 25 per 100 enterocytes).
Marsh 2: Crypt hyperplasia.
Marsh 3: Partial, subtotal, or total villous atrophy .
Treatment: Lifelong strict Gluten-Free Diet (GFD) .
Malignancy Risk: Long-term untreated disease increases the risk of Enteropathy-Associated T-Cell Lymphoma (EATL) and small bowel adenocarcinoma.
2. Tropical Sprue
Chronic malabsorptive disorder affecting residents of or visitors to tropical areas (e.g., India, Southeast Asia, Caribbean).
Involves the entire small intestine (duodenum, jejunum, and ileum), leading to dual Vitamin B 12 \text{B}_{12} B 12 and Folate deficiency → \rightarrow → severe megaloblastic anemia.
Histopathology shows blunting of villi (less severe than Celiac disease).
Treatment: Oral Tetracycline (or Doxycycline) 250 mg QID PLUS Folic acid 5 mg daily for 3 to 6 months .
3. Whipple Disease
Rare systemic infectious disease caused by the Gram-positive actinomycete Tropheryma whipplei .
Classic Clinical Quadrad: Malabsorption (diarrhea, weight loss), Migratory Large Joint Arthralgias , Hyperpigmentation, and Low-grade Fever/Lymphadenopathy (may cause culture-negative endocarditis and CNS cognitive symptoms).
Pathognomonic Histopathology: Small bowel duodenal biopsy showing PAS-positive (Periodic acid-Schiff), acid-fast negative macrophages filling the lamina propria and compressing lymphatic lacteals.
Treatment: Intravenous Ceftriaxone (or Penicillin G) for 2–4 weeks followed by oral Trimethoprim-Sulfamethoxazole (TMP-SMX) for 12 months .